Literature DB >> 35586083

Right Ventricular Involvement of an Aggressive Malignant Peripheral Nerve Sheath Tumor.

Saikrishna Patibandla1, Miklos Auber2, Stell Patadji3, Yasmin Hamirani1.   

Abstract

We present a case of a 58-year-old woman who had a painful right thigh mass for a few months. A transthoracic echocardiogram revealed no evidence of an intracardiac mass. She had a whole-body positron emission tomography/computed tomography scan two months later that revealed masses in her right lower extremity and a mass in her right ventricle that had not been initially reported. She had been initially diagnosed with an undifferentiated pleomorphic sarcoma, but this diagnosis was changed to a malignant peripheral nerve sheath tumor with repeat pathology. She was subsequently hospitalized. An echocardiogram showed a mass covering 80% of her right ventricle (RV). Serial cardiac magnetic resonance imaging revealed a 9.4 × 5.6 cm RV mass with vascular and avascular portions and inflow and outflow tract obstruction. Computed tomography showed no other metastases. Due to a delay in diagnosis and a decline in left ventricular ejection fraction, the patient could not undergo palliative chemotherapy or radiotherapy. Copyright Journal of Radiology Case Reports.

Entities:  

Keywords:  Malignant peripheral nerve sheath tumor; cardiac magnetic resonance imaging; cardiac metastasis; peripheral magnetic resonance imaging; transthoracic echocardiography

Mesh:

Year:  2022        PMID: 35586083      PMCID: PMC9063830          DOI: 10.3941/jrcr.v16i1.4338

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN: 1943-0922


  18 in total

Review 1.  Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine.

Authors:  Adriana C Gamboa; Alessandro Gronchi; Kenneth Cardona
Journal:  CA Cancer J Clin       Date:  2020-04-10       Impact factor: 508.702

Review 2.  MR imaging of cardiac tumors and masses: a review of methods and clinical applications.

Authors:  Manish Motwani; Ananth Kidambi; Bernhard A Herzog; Akhlaque Uddin; John P Greenwood; Sven Plein
Journal:  Radiology       Date:  2013-07       Impact factor: 11.105

3.  Malignant schwannoma--clinical characteristics, survival, and response to therapy.

Authors:  P P Sordillo; L Helson; S I Hajdu; G B Magill; C Kosloff; R B Golbey; E J Beattie
Journal:  Cancer       Date:  1981-05-15       Impact factor: 6.860

4.  Metastatic malignant peripheral nerve sheath tumor. A diagnostic surprise.

Authors:  Muniza Bai; Vishnukanth Govindaraj; Abhishek Singh Chauhan; Bheemanati Hanuman Srinivas; Jinkala Sree Rekha; Vijayarangam Narenchandra
Journal:  Monaldi Arch Chest Dis       Date:  2021-05-06

5.  Malignant peripheral nerve sheath tumors: differentiation patterns and immunohistochemical features - a mini-review and our new findings.

Authors:  Aitao Guo; Aijun Liu; Lixin Wei; Xin Song
Journal:  J Cancer       Date:  2012-07-04       Impact factor: 4.207

6.  Multimodality imaging evaluation of a primary cardiac lymphoma.

Authors:  Paolo Ciancarella; Armando Fusco; Daniele Citraro; Massimiliano Sperandio; Roberto Floris
Journal:  J Saudi Heart Assoc       Date:  2016-09-20

Review 7.  Diagnosis and management of malignant peripheral nerve sheath tumors: Current practice and future perspectives.

Authors:  Bethany C Prudner; Tyler Ball; Richa Rathore; Angela C Hirbe
Journal:  Neurooncol Adv       Date:  2019-11-14

8.  Immunohistochemical Diagnosis of Primary Cardiac Leiomyosarcoma in a Latin American Patient.

Authors:  Ruben Blachman-Braun; Carlos Manuel Aboitiz-Rivera; Alberto Aranda-Fraustro; Adrián Ransom-Rodríguez; Mario Enrique Baltazares-Lipp; Jorge Manuel Catrip-Torres; Jesús Octavio Martínez-Reding
Journal:  Rare Tumors       Date:  2017-03-28

9.  Prognosis and risk factors for malignant peripheral nerve sheath tumor: a systematic review and meta-analysis.

Authors:  Zhenyu Cai; Xiaodong Tang; Haijie Liang; Rongli Yang; Taiqiang Yan; Wei Guo
Journal:  World J Surg Oncol       Date:  2020-09-30       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.